Curated News
By: NewsRamp Editorial Staff
September 02, 2026
20Slash20's Eye Drink to Shine at Moody Capital's 2026 Conference
TLDR
- 20Slash20's Eye Drink offers a unique market advantage as the first functional beverage targeting screen-induced eye issues, poised to capture a growing segment.
- The Eye Drink uses AREDS 2-based nutrients and vegan Omega-3 to support eye health, distributed via DTC, medical affiliates, and retail stores.
- By providing a convenient, science-backed drink, 20Slash20 helps reduce eye strain for millions who work long hours on screens, improving daily comfort.
- Discover the world's first drink formulated to combat dry eyes and macular damage from screen use, turning clinical science into a tasty daily habit.
Impact - Why it Matters
This news matters because it highlights a novel solution to a widespread modern problem: the detrimental effects of blue light and screen time on eye health. With millions of people spending hours daily on digital devices, products like The Eye Drink offer a convenient, scientifically backed approach to preventive eye care. The conference participation not only provides exposure for 20Slash20 but also signals to investors and consumers that functional beverages targeting specific health concerns are an emerging trend with significant market potential. For readers, this could mean new options to protect their vision in a screen-dominated world, and it underscores the importance of proactive health measures.
Summary
20Slash20, the innovator behind The Eye Drink, is set to present at the Moody Capital Solutions 2026 Disruptive Growth and Life Sciences Conference. The Eye Drink is the world's first clinically inspired, ready-to-drink functional beverage formulated to combat the negative effects of prolonged screen time, such as dry eyes and macular damage. Leveraging science-backed nutrients based on AREDS 2 Studies and vegan-friendly Omega-3, the drink aims to protect visual performance and enhance ocular comfort. With a distribution strategy spanning direct-to-consumer, professional medical affiliates, and natural product retail stores, 20Slash20 is modernizing preventive eyecare by turning clinical science into a simple daily habit. For more details, visit theeyedrink.com.
The conference, organized by Moody Capital Solutions Inc., an independent investment bank with over 40 years of experience, will highlight disruptive growth companies in the life sciences sector. IBN, a multifaceted financial news and publishing company, is providing comprehensive coverage through a custom-built portal, social media, and syndicated articles to maximize visibility. Attendees can register via moodycapital.com/conference, and IBN's coverage can be accessed through the provided links. This event offers a platform for innovative companies like 20Slash20 to showcase their potential to investors, emphasizing the growing intersection of health and technology.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, 20Slash20's Eye Drink to Shine at Moody Capital's 2026 Conference
